Search research articles
Contact Us
Filters
Showing results (11-20 of 87) with videos related to
Page
of 9
Sort By:
Pharmacology & Therapeutics
|
January 29, 2016
Plasma membrane calcium ATPases (PMCAs) as potential targets for the treatment of essential hypertension
Robert Little, Elizabeth J Cartwright, Ludwig Neyses, et al.
Biofactors (Oxford, England)
|
June 16, 2011
Calcium signaling dysfunction in heart disease
Elizabeth J Cartwright, Tamer Mohamed, Delvac Oceandy, et al.
Science China. Life Sciences
|
July 26, 2011
Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps
Elizabeth J Cartwright, Delvac Oceandy, Clare Austin, et al.
The Journal of Physiology
|
October 13, 2017
Plasma membrane Ca<sup>2+</sup> -ATPase 1 is required for maintaining atrial Ca<sup>2+</sup> homeostasis and electrophysiological stability in the mouse
Yanwen Wang, Claire Wilson, Elizabeth J Cartwright, et al.
Mini Reviews in Medicinal Chemistry
|
May 25, 2006
The emergence of plasma membrane calcium pump as a novel therapeutic target for heart disease
Delvac Oceandy, Mamta H Buch, Elizabeth J Cartwright, et al.
Biochimica Et Biophysica Acta
|
December 21, 2010
Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4)
Delvac Oceandy, Tamer M A Mohamed, Elizabeth J Cartwright, et al.
Physiological Reviews
|
June 2, 2017
The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease
Nicholas Stafford, Claire Wilson, Delvac Oceandy, et al.
Journal of Molecular and Cellular Cardiology
|
March 30, 2021
Plasma membrane calcium ATPase 1 regulates human umbilical vein endothelial cell angiogenesis and viability
Alexandra Njegic, Agnieszka Swiderska, Charlotte Marris, et al.
FEBS Open Bio
|
November 11, 2017
Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
Zeinab Hegab, Tamer M A Mohamed, Nicholas Stafford, et al.
Journal of Cellular and Molecular Medicine
|
December 2, 2017
Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS-dependent mechanism
Sophronia Lewis, Robert Little, Florence Baudoin, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 87) with videos related to
Sort By:
Page
of 9
Pharmacology & Therapeutics
|
January 29, 2016
Plasma membrane calcium ATPases (PMCAs) as potential targets for the treatment of essential hypertension
Robert Little, Elizabeth J Cartwright, Ludwig Neyses, et al.
Biofactors (Oxford, England)
|
June 16, 2011
Calcium signaling dysfunction in heart disease
Elizabeth J Cartwright, Tamer Mohamed, Delvac Oceandy, et al.
Science China. Life Sciences
|
July 26, 2011
Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps
Elizabeth J Cartwright, Delvac Oceandy, Clare Austin, et al.
The Journal of Physiology
|
October 13, 2017
Plasma membrane Ca<sup>2+</sup> -ATPase 1 is required for maintaining atrial Ca<sup>2+</sup> homeostasis and electrophysiological stability in the mouse
Yanwen Wang, Claire Wilson, Elizabeth J Cartwright, et al.
Mini Reviews in Medicinal Chemistry
|
May 25, 2006
The emergence of plasma membrane calcium pump as a novel therapeutic target for heart disease
Delvac Oceandy, Mamta H Buch, Elizabeth J Cartwright, et al.
Biochimica Et Biophysica Acta
|
December 21, 2010
Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4)
Delvac Oceandy, Tamer M A Mohamed, Elizabeth J Cartwright, et al.
Physiological Reviews
|
June 2, 2017
The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease
Nicholas Stafford, Claire Wilson, Delvac Oceandy, et al.
Journal of Molecular and Cellular Cardiology
|
March 30, 2021
Plasma membrane calcium ATPase 1 regulates human umbilical vein endothelial cell angiogenesis and viability
Alexandra Njegic, Agnieszka Swiderska, Charlotte Marris, et al.
FEBS Open Bio
|
November 11, 2017
Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
Zeinab Hegab, Tamer M A Mohamed, Nicholas Stafford, et al.
Journal of Cellular and Molecular Medicine
|
December 2, 2017
Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS-dependent mechanism
Sophronia Lewis, Robert Little, Florence Baudoin, et al.
Page
of 9